Expression of a mutant human fibrillin allele upon a normal human or murine genetic background recapitulates a Marfan cellular phenotype

Journal of Clinical Investigation

Volumn 95, Issue 2, 1995, Pages 874-880

  Eldadah, Zayd A ^a   Brenn, Thomas ^b   Furthmayr, Heinz ^b   Dietz, Harry C ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRILLIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MARFAN SYNDROME; MICROTUBULE ASSEMBLY; NONHUMAN; PRIORITY JOURNAL;

EID: 0028831359     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/jci117737     Document Type: Article

References (29)

1. McKusick, V. A. 1972. Heritable Disorders of Connective Tissue. 4th ed. CV Mosby, St. Louis, MO. 61-223.
2. Pyeritz, R. E., and V. A. McKusick. 1979. The Marfan syndrome: diagnosis and management. N. Engl. J. Med. 300:772-777.
3. Pyeritz, R. E. 1990. Marfan syndrome. In Principles and Practice of Medical Genetics. Second edition. A. E. H. Emery and D. L. Rimoin, editors. Churchill-Livingstone, Inc., New York. 1047-1063.
4. Kainulainen, K., L. Pulkkinen, A. Savolainen, I. Kaitila, and L. Peltonen. 1990. Location on chromosome 15 of the gene defect causing Marfan syndrome. N. Engl. J. Med. 323:935-939.
5. Dietz, H. C., G. R. Cutting, R. E. Pyeritz, C. L. Maslen, L. Y. Sakai, G. M. Corson, E. G. Puffenberger, A. Hamosh, E. Nanthakumar, S. Curristin, et al. 1991. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature (Lond.). 352:337-339.
6. Lee, B., M. Godfrey, E. Vitale, H. Hori, M.-G. Mattei, M. Sarfarazi, P. Tsipouras, F. Ramirez, and D. W. Hollister. 1991. Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature (Lond.). 352:330-334.
7. Sakai, L. Y., D. R. Keene, and E. Engvall. 1986. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J. Cell Biol. 103:2499-2509.
8. Sakai, L. Y., D. R. Keene, R. W. Glanville, and H. P. Bachinger. 1991. Purification and partial characterization of fibrillin, a cysteine-rich structural component of connective tissue microfibrils. J. Biol. Chem. 266:14763-14770.
9. Maslen, C. L., G. M. Corson, B. K. Maddox, R. W. Glanville, and L. Y. Sakai. 1991. Partial sequence of a candidate gene for the Marfan syndrome. Nature (Lond). 352:334-337.
10. Corson, G. M., S. C. Chalberg, H. C. Dietz, N. L. Charbonneau, and L. Y. Sakai. 1993. Fibrillin binds calcium and is encoded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5′ end. Genomics. 17:476-484.
11. Ramirez, F., L. Pereira, H. Zhang, and B. Lee. 1993. The fibrillin-Marfan syndrome connection. Bioessays. 15:589-594.
12. Milewicz, D. M., R. E. Pyeritz, E. S. Crawford, and P. H. Byers. 1992. Marfan syndrome: defective synthesis, secretion and extracellular matrix formation of fibrillin by cultured dermal fibroblasts. J. Clin. Invest. 89:79-86.
13. Keene, D. R., B. K. Maddox, H. J. Kuo, L. Y. Sakai, and R. W. Glanville. 1991. Extraction of extendable beaded structures and their identification as fibrillin-containing extracellular matrix microfibrils. J. Histochem. Cytochem. 39:441-449.
14. Maddox, B. K., L. Y. Sakai, D. R. Keene, and R. W. Glanville. 1991. Connective tissue microfibrils: isolation and characterization of three large pepsin-resistant domains of fibrillin. J. Biol. Chem. 264:21381-21385.
15. Aoyama, T., K. Tynan, H. C. Dietz, U. Francke, and H. Furthmayr. 1993. Missense mutations impair intracellular processing of fibrillin and microfibril assembly in Marfan syndrome. Hum. Mol. Gen. 2:2135-2140.
16. Aoyama, T., U. Francke, H. C. Dietz, and H. Furthmayr. 1994. Quantitative differences in biosynthesis and extracellular deposition of fibrillin in cultured fibroblasts distinguish five groups of Marfan syndrome patients and suggest distinct pathogenic mechanisms. J. Clin. Invest. 94:130-137.
17. Dietz, H. C., I. McIntosh, L. Y. Sakai, G. M. Corson, S. C. Chalberg, R. E. Pyeritz, and C. A. Francomano. 1993. Four novel FBN1 mutations: ignificance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. Genomics. 17:468-475.
18. Hollister, D. W., M. Godfrey, L. Y. Sakai, and R. E. Pyeritz. 1990. Immunohistologic abnormalities of the microfibrillar-fiber system in the Marfan syndrome. N. Engl. J. Med. 323:152-159.
19. Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517.
20. Dietz, H. C., R. E. Pyeritz, E. G. Puffenberger, R. J. Kendzior, G. M. Corson, C. L. Maslen, L. Y. Sakai, and C. A. Francomano. 1992. Marfan phenotype variability in a family segregating a missense mutation in the epidermal growth factor-like motif of the fibrillin gene. J. Clin. Invest. 89:1674-1680.
21. Urlaub, G., P. J. Mitchell, C. J. Ciudad, and L. A. Chasin. 1989. Nonsense mutations in the dihydrofolate reductase gene affect RNA processing. Mol. Cell. Biol. 9:2868-2880.
22. Cheng, J., M. Fogel-Petrovic, and L. E. Maquat. 1990. Translation to near the distal end of the penultimate exon is required for normal levels of spliced triosephosphate isomerase mRNA. Mol. Cell. Biol. 10:5215-5225.
23. Glesby, M. J., and R. E. Pyeritz. 1989. Association of mitral valve prolapse and systemic abnormalities of connective tissue: a phenotypic continuum. J. Am. Med. Assoc. 262:523-528.
24. Prockop, D. J., A. Colige, H. Helminen, J. S. Khillan, R. Pereira, and P. Vandenberg. 1993. Mutations in type 1 procollagen that cause osleogenesis imperfecta: effects of the mutations on the assembly of collagen into fibrils, the basis of phenotypic variations, and potential antisense therapies. J. Bone Miner. Res. 2:S489-492.
25. Davis, C. G. 1990. The many faces of epidermal growth factor repeats. New Biol. 2:410-419.
26. Cooke, R. M., A. J. Wikinson, M. Baron, A. Pastore, M. J. Tappin, I. D. Campbell, H. Gregory, and B. Sheard. 1987. The solution structure of human epidermal growth factor. Nature (Lond.). 327:339-341.
27. Handford, P. A., M. Mayhew, M. Baron, P. R. Winship, I. D. Campbell, and G. G. Brownlee. 1991. Key residues involved in calcium binding motifs in EGF-like domains. Nature (Lond.). 351:164-167.
28. Hewett, D. R., J. R. Lynch, R. Smith, and B. C. Sykes. 1993. A novel fibrillin mutation in the Marfan syndrome which could disrupt calcium binding of the epidermal growth factor-like module. Hum. Mol. Genet. 2:475-477.
29. Kielty, C. M., and C. A. Shuttleworth. 1993. The role of calcium in the organization of fibrillin microfibrils. FEBS (Fed. Eur. Biochem. Soc.). 336:323-326.